We are currently accepting graduate students and postdocs to join our lab.

To learn more about our available postdoc position, click here. To apply, click here.

Please contact us if you are interested in joining our team.

The lab of Dr. Jennifer Guerriero's recent R01 award has been promoted to an R37 MERIT award. Congratulations to her team on this tremendous accomplishment!

Congratulations to graduate student Ellie Hunt for the acceptance of her paper titled "The ER-mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors" in Frontiers in Cell and Developmental Biology!

Welcome Evelyn!

Evelyn Gandy is a senior undergraduate student at UNC majoring in Psychology and minoring in Biology and Chemistry. We are excited to have her join our team!

The Thaxton lab has joined the University of North Carolina at Chapel Hill!

We are excited to join the team of dedicated researchers in the cancer immunotherapy group in Marsico Hall.

A big congratulations to Dr. Kristen Wallace for her recent publication in Cancer Prevention Research titled "Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology."

Click here to read more about Dr. Wallace's figure that made it on to the cover of this issue!

Congratulations to Guillermo Rangle-Rivera, PhD candidate, on his recent publication titled "Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy" in Frontiers in Immunology!

Aubrey Smith, PhD candidate, has a paper in press in the Journal for Immunotherapy of Cancer titled "B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity." Congratulations Aubrey!

Congratulations to the lab of Dr. Jennifer Guerriero on publishing their paper in Nature Cancer titled "Targeting Immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer"!

Two R01 grants have been awarded by NCI/NIH to the Thaxton lab in 2020 as part of  the Cancer Moonshot Initiative on Immunometabolism!

1RO1CA348359-010: 4/01/2020 - 03/31/2025

Exploitation of ER Stress Induced Immune Dysfunction to Improve Cancer Immunotherapy

​

1R01CA244361-01A1: 7/1/2020 - 6/30/2025

Targeting Chronic ER Stress in T-Cells to Improve Cancer Immunotherapy